|
 Provided by: ReachMD
Login or Register for additional programming information
Program Description
"The FDA's Safe Use Initiative" - FDA Voice
Host Dr. Charles Turck talks with Dr. Karen Weiss, project lead for the FDA's Safe Use Initiative, and Dr. Dale Slavin, senior policy analyst. How is the FDA working to ensure that medications are used optimally once they’re available to the public? This program explains this collaborative initiative to address various types of preventable harm from medications.
 Charles J Turck, Pharm.D., BCPS, is a pharmacist at UMass Memorial Medical Center and an adjunct clinical instructor at the Massachusetts College of Pharmacy and Health Sciences. He has completed a pharmacy practice residency at UMass as well as a specialty residency in Drug Information at Rutgers - The State University of New Jersey's Ernest Mario School of Pharmacy and Robert Wood Johnson University Hospital, where Dr. Turck also served as chief pharmacy resident. Dr. Turck has led and collaborated on a variety of pharmacy- and drug-related topics and has several publications to his name. He earned his Bachelor of Science in Pharmacy in 2003 and his Doctor in Pharmacy in 2004 from Midwestern University Chicago College of Pharmacy. Dr. Turck has been involved in the profession of pharmacy for over a decade, with humble beginnings as a pharmacy technician in 1996.
The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.
RECOMMEND THIS ARTICLE
You must be logged in
to recommend articles
| 
